GDF-8 (1mg)

GDF-8 (1mg), also known as myostatin, is a regulatory protein involved in controlling muscle growth. Research protocols involving GDF-8 focus on its role in muscle homeostasis, cellular signaling, and metabolic regulation. This guide outlines a subcutaneous research-use approach tailored to the 1 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 1 mg/mL concentration
  • Typical research range: 50–200 mcg per administration (subcutaneous)
  • Easy measuring: At 1 mg/mL, 1 unit = 0.01 mL = 10 mcg on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous research regimen.

  • Goal: Study muscle growth regulation and myostatin signaling pathways
  • Schedule: 2–3 administrations per week, depending on research design
  • Dose Range: 50–200 mcg per dose

Suggested approach for the 1 mg vial format (research context).

  • Start: 50 mcg per administration
  • Target: 100–200 mcg per administration
  • Frequency: 2–3 times per week (subcutaneous)
  • Vial Duration: One 1 mg vial lasts approximately 5–20 administrations
  • Timing: Evenly spaced dosing (e.g., every 2–3 days)

GDF-8 (Growth Differentiation Factor-8), commonly referred to as myostatin, is a member of the TGF-β (transforming growth factor-beta) superfamily. It acts as a negative regulator of muscle growth by inhibiting myoblast proliferation and differentiation.

By binding to activin type II receptors (ActRIIB), GDF-8 activates intracellular signaling pathways that limit muscle cell growth and protein synthesis. This mechanism plays a critical role in maintaining muscle size and preventing excessive hypertrophy. Variations or inhibition of this pathway have been widely studied in relation to muscle development, strength, and metabolic regulation.

Observations based on research and biological role.

Potential Applications (Research Context):

  • Helps study muscle growth regulation mechanisms
  • Useful in research on muscle wasting and metabolic disorders
  • Provides insight into myostatin-related signaling pathways

Considerations / Possible Effects:

  • May reduce muscle growth due to its inhibitory role
  • Potential for decreased muscle mass with higher exposure
  • Injection-site irritation possible
  • Not intended for therapeutic use; long-term effects in humans are not established